Things that You Have to Know About Bipolar Depression
Know that bipolar disorder is one type of condition that would affect all kinds of people. Both children and adults would get affected by such kind of condition. This is a fact that you should know. The women are going to suffer the most from such type of depression which is called bipolar depression disorder.
It is not strange in any case since even if women suffer from such regular bipolar kind of depression or a depressive disorder, they would spend more time depressed than they do being manic. Not just women are depressive but the men would also get affected by such kind of condition.
The bipolar type of disorder is known as manic depression because this is a mental condition wherein you would interchange often between the phases of mania and depression. When you suffer from bipolar depression, you will not have to spend as much time being manic as you spend being depressed.
This type of depression is one form of disorder and you should understand that it is really easy to wrongly diagnose as bipolar disorder due to the similarity in their symptoms. Because of such, the doctor must keep you around for such a long time when they would try to diagnose the condition you have. It is surely not flattering to either of you when you get treated for a wrong thing.
The bipolar affective disorder is another name for such bipolar disorder or the manic-depressive illness. But, you don’t like to mistake this for bipolar depression disorder. Such is closely related with all of the symptoms of such depressive phase of the bipolar disorder, but very few of the mania.
The monotherapy trials against the placebo continue to be the gold-standard design when it comes to determining the efficacy in bipolar depression. When such efficacy would be proven as monotherapy, the new compounds can be tested in the adjunctive-medication placebo-controlled trials. Those younger adults, without the established need for such long-term medication can be suitable for the clinical trials needing placebo-controls. The switch to mania or hypomania can be the consequence of such active treatment for the bipolar depression.
Some of the medications like the tricyclic antidepressants as well as venlafaxine can be more likely to prove switch than the others but the increased rate of the switch cannot be seen until around ten weeks of treatment. The 12-week trials against placebo are needed to determine the risk of switch and also to establish the continuing effects. You should know that careful assessment at 6-8 weeks are required to make sure that the patients who fail to respond won’t continue in the study for the unacceptable periods of time.